RONELA MAE JAVATE-ULANDAY: Open Payments
NPI 1780461418 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 18 payments from 9 companies in 2025. Trend: 2023 $61 · 2024 $477 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 9 | $226 |
| Lilly USA, LLC | 2 | $147 |
| Grifols USA, LLC | 1 | $125 |
| ABBVIE INC. | 1 | $99 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Amgen Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
Products named: Leqembi, Prolastin-C Liquid, OMVOH, VRAYLAR, ULTOMIRIS, BKEMV, Ocrevus Zunovo, Rystiggo.
Industry payments across NV — which companies pay providers there.
